About My Health Careers Internship MedBlogs Contact us

Treatment of Chronic Obstructive Pulmonary Disease or COPD: New Revelations

Font : A-A+

Treatment of Chronic Obstructive Pulmonary Disease or COPD: New Revelations

New findings may alter the treatment guidelines of COPD. The drug tiotropium has been found to be more effective than salmeterol in preventing exacerbations.


Chronic obstructive pulmonary disease (COPD) is one of the most common lung diseases that make it difficult to breathe. It is a leading cause of disability and death worldwide. The more a person smokes, the more likely that person will develop COPD. There is no complete cure for COPD. All that can be done is to relieve symptoms and keep the disease from getting worse. The best way to slow down lung damage is to stop smoking.

The prevention of exacerbations constitutes a major goal of treatment. Exacerbations of COPD indicate instability or worsening of the patient's clinical status and progression of the disease. Exacerbations are associated with the development of complications, an increased risk of subsequent exacerbations, reduced health status and physical activity, deterioration of lung function, and an increased risk of death.

Medications used include:

Inhalers (bronchodilators) to open the airways, such as ipratropium, tiotropium, salmeterol, or formoterol

Inhaled steroids to reduce lung inflammation

Tiotropium belongs to a group of drugs called anticholinergics. These work by blocking specific neurotransmitters in the nervous system. Salmeterol is a 2-agonist, i.e. part of the class of drugs that relaxes smooth muscles. Both of these drugs reduce symptoms, improve quality of life and lung function, and reduce the risk of exacerbations and hospitalizations. Therapy with a long-acting anticholinergic drug or a long-acting 2-agonist is recommended as first-line maintenance therapy in patients with moderate-to-very-severe COPD.

A recent study compared both. Researchers investigated whether the anticholinergic drug tiotropium is superior to the 2-agonist salmeterol in preventing exacerbations of COPD. The study was performed at 725 centers in 25 countries to compare the effect of tiotropium with that of salmeterol. A total of 7384 patients were involved.

The one year long trial concluded that tiotropium was more effective. 'In patients with moderate-to-very-severe COPD, tiotropium is more effective than salmeterol in preventing exacerbations', writes authors. Results were published in the New England Journal of Medicine (NEJM), the leading medical journal. Time to first exacerbation was significantly longer with tiotropium.

None of the treatment guidelines specify whether a long-acting anticholinergic drug or a 2-agonist is the preferred agent. The new study results would bring a change to this.

Source: Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD. Claus Vogelmeier, M.D., Bettina Hederer, M.D., Thomas Glaab, M.D., Hendrik Schmidt, Ph.D., Maureen P.M.H. Rutten-van Mlken, Ph.D., Kai M. Beeh, M.D., Klaus F. Rabe, M.D., and Leonardo M. Fabbri, M.D. for the POET-COPD Investigators. N Engl J Med 2011; 364:1093-1103; March 24, 2011.

Source: Medindia

News A-Z
News Category
What's New on Medindia
Convulsions / Seizures / Fits - Symptom Evaluation
World Heart Day 2021 -
Are Black Foods the New Superfood?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Amoebic Dysentery Silicosis Emphysema Pulmonary Edema Pneumonectomy Drug-induced Pulmonary Diseases 

Recommended Reading
Chronic Obstructive Pulmonary Disease
COPD includes respiratory tract disorders that cause obstruction to airflow. These are chronic .....
Experimental Treatment for COPD on the Anvil
A non-steroid based strategy for improving the lung''s innate immune defense and decreasing ......
COPD Patient Mortality Decreased by New Therapy
Patients with severe COPD may benefit more from therapy that combines salmeterol and fluticasone ......
Amoebic Dysentery
Amoebic dysentery or amoebiasis is an infection of the intestine that causes diarrhoea most frequent...
Drug-induced Pulmonary Diseases
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced pulmona...
Emphysema is a chronic obstructive pulmonary disease, marked by alveolar damage, and reduced air flo...
Pulmonary Edema
Pulmonary edema or fluid in the lungs is caused by congestive heart failure and several other condit...
Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterise...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use